Black men are more likely to be diagnosed with prostate cancer and less likely to receive radical treatment for high-risk cases compared to white men, a new report by the National Prostate Cancer Audit has found. 

The National Prostate Cancer Audit (NPCA) State of the Nation Report, published in January 2025, evaluates prostate cancer rates and the care provided to men diagnosed with the disease in England and Wales between 1st Jan 2019 and 31st Dec 2023. 

Key Findings: 

Diagnosis 

• England: 9% rise in diagnoses in 2023 (55,241 cases) compared to 2022; a 25% rise since 2019.
• Wales: 26% rise in diagnoses in 2022 (2,521 cases) compared to 2021.
• Black populations across all ages had more diagnoses per 1000 men than other ethnicities.
• White men aged 85+ were more frequently diagnosed at stage 4. 

Treatment

• England: Radical prostatectomy and radiotherapy increased by 17% and 23% respectively in 2023 compared to 2022. 
• Wales: Corresponding increases were 11% and 25% in 2022 compared to 2021. 
• Hypofractionated and stereotactic radiotherapy are replacing conventional radiotherapy.
• Black men and those in more deprived areas were less likely to get radical treatment for high-risk or locally advanced disease.

Read the full report here - https://www.npca.org.uk/wp-content/uploads/2025/01/NPCA-State-of-the-Nation-Report-2024_v2.pdf